Approved indications: The transdermal scopolamine patch is approved in adults to prevent nausea and vomiting caused by motion sickness and to prevent postoperative nausea and vomiting (PONV) during recovery from anesthesia and opioid pain medicines after surgery.

Off-label uses and evidence: Clinicians sometimes use the patch off label for vestibular disorders (such as vertigo), chronic or refractory nausea, and to reduce drooling or excess secretions in neurologic or palliative-care patients; evidence for these uses comes mainly from small studies and case series, so benefits are less certain than for motion sickness and PONV.

Efficacy expectations: For motion sickness and PONV, scopolamine meaningfully lowers the chance and severity of nausea and vomiting compared with no treatment, with effects beginning about 4 hours after application and becoming strongest by 24 hours, and a single patch provides protection for up to 72 hours.

Comparison to similar drugs: Compared with oral antihistamines (like dimenhydrinate or meclizine), the patch offers longer, steadier protection with fewer repeat doses but similar or greater anticholinergic side effects; compared with 5‑HT3 antagonists (like ondansetron), it is generally more sedating and anticholinergic but useful as part of combination therapy, especially when prolonged prevention is needed.

Typical adult dosing (motion sickness): Apply one transdermal patch to a clean, dry, hairless area behind one ear at least 4 hours before motion exposure; each patch delivers about 1 mg of scopolamine over 3 days and may be worn for up to 72 hours, after which it should be removed and, if needed, replaced with a new patch behind the opposite ear.

Typical adult dosing (postoperative nausea and vomiting): For most surgeries, one patch is applied behind the ear the evening before surgery (or at least several hours before anesthesia) and is usually removed 24 hours after surgery; it is intended for short-term use around the surgical period.

Use in children and older adults: The transdermal patch is not approved for use in children, and older adults are more prone to confusion, hallucinations, and urinary problems, so extra monitoring and sometimes lower-risk alternatives are considered.

How to apply and wear: Do not cut the patch, and wear only one at a time; press firmly when applying, avoid touching the sticky surface, wash hands thoroughly afterward, avoid rubbing the patch area, and keep it away from external heat sources (such as heating pads or heated blankets); remove the patch before MRI scans because the backing may contain metal that can overheat.

Special dosing instructions: If a patch falls off or becomes loose, discard it safely and apply a new one behind the other ear; for long trips or prolonged risk, replace the patch every 72 hours as directed by your clinician, and do not exceed the recommended number or duration of patches without medical supervision.

Missed dose guidance: If you forget to apply a patch in time, put one on as soon as you remember, understanding that full effect may take several hours; do not apply extra patches to "catch up" for a missed or late dose.

Overdose management: Symptoms of overdose include extreme dry mouth, very fast heartbeat, flushed or very hot skin, severe agitation, confusion, hallucinations, seizures, or loss of consciousness; remove all patches immediately and seek emergency care or contact poison control right away.

Common side effects: Very common effects include dry mouth, drowsiness, dizziness, blurred vision or dilated pupils (especially if medicine gets in the eye), and mild local skin irritation where the patch is applied; these usually start within the first day and are generally mild to moderate but may be bothersome.

Serious or rare adverse effects: Seek immediate medical attention for eye pain, red eyes, or halos around lights (possible acute angle-closure glaucoma); confusion, agitation, hallucinations, or severe disorientation; trouble urinating or inability to pass urine; signs of severe allergy (rash, swelling, trouble breathing); seizures; or signs of dangerous overheating such as very high body temperature, hot or very dry skin, lack of sweating in heat, confusion, or loss of consciousness.

Warnings and special populations: The patch is contraindicated in people with angle-closure glaucoma and in anyone with a known serious allergy to scopolamine or other belladonna alkaloids; it is not approved for pediatric patients, and children are particularly sensitive to side effects.

Pregnancy and breastfeeding: In pregnancy, scopolamine is used only if the expected benefit outweighs potential risks and should be avoided in women with severe preeclampsia because of seizure risk; in breastfeeding, small amounts may enter milk and long-term use could reduce milk supply, so clinicians typically use the lowest effective dose for the shortest time and monitor the infant and milk production.

Other medical conditions: Use with caution in older adults; people with urinary retention or enlarged prostate; bowel obstruction or severe constipation; myasthenia gravis; seizure disorders; or heart disease, because anticholinergic and CNS effects can worsen these conditions.

Relative safety compared with alternatives: Compared with many modern antiemetics, scopolamine has a higher burden of anticholinergic effects (dry mouth, vision changes, confusion), particularly in the elderly, but offers the advantage of long, steady dosing without injections or frequent pills.

Staying informed and reporting problems: Patients and caregivers can report suspected side effects to the FDA’s MedWatch program and should review current Medication Guides or FDA Drug Safety Communications for updates on risks such as hyperthermia and neuropsychiatric reactions.

Interactions with other medicines and substances: Scopolamine’s sedating and anticholinergic effects can be increased by alcohol, sleep medicines, opioids, benzodiazepines, sedating antihistamines, tricyclic antidepressants, antipsychotics, muscle relaxants, and other anticholinergic drugs (such as some bladder, Parkinson’s, or irritable bowel medicines), raising the risk of severe drowsiness, confusion, constipation, urinary retention, overheating, and vision problems.

Other drug and procedure interactions: Scopolamine can oppose the effects of pro-motility drugs like metoclopramide and may worsen glaucoma or eye pressure problems if combined with other mydriatic or anticholinergic eye medicines; the patch should be removed before MRI because the backing may heat up, causing skin burns.

Food and alcohol: There are no major food restrictions, but alcohol and cannabis should be limited or avoided because they add to drowsiness and impaired coordination.

Conditions requiring extra caution: Use carefully in people with open-angle glaucoma (eye pressure should be monitored), urinary retention or prostate enlargement, bowel obstruction or severe constipation, myasthenia gravis, seizure disorders, severe heart disease, or those exposed to high environmental heat, as scopolamine can worsen these problems.

Monitoring needs: Clinicians may monitor for changes in vision or eye pain, mental status (confusion, agitation, hallucinations), heart rate, urination, bowel function, and signs of overheating, especially in older adults, people with neurologic or psychiatric illness, and those taking other CNS-active or anticholinergic medicines.

Q: How long does a scopolamine patch last and when should I put it on?
A: Each patch is designed to deliver medicine steadily for up to 72 hours, and for the best effect it should be applied behind the ear at least 4 hours before you expect motion exposure or surgery-related nausea.

Q: Can I drive or operate machinery while wearing the patch?
A: The patch can cause drowsiness, blurred vision, and slowed reaction time, so you should not drive, operate heavy machinery, or do risky tasks until you know exactly how it affects you.

Q: Is the scopolamine patch safe during pregnancy and breastfeeding?
A: In pregnancy it is used only when clearly needed and should be avoided in women with severe preeclampsia, while in breastfeeding small amounts may enter milk and long-term use can affect milk supply, so clinicians usually use the lowest effective dose for the shortest time and monitor the baby and feeding.

Q: What should I do if the patch falls off or gets very wet?
A: If a patch comes off or peels away, throw it away safely and apply a new one behind the other ear, and do not tape a loose patch back on or wear more than one at once.

Q: Can I cut a scopolamine patch to lower the dose?
A: No, the patch must not be cut because this disrupts the controlled-release system and can lead to unpredictable dosing and side effects.

Q: What happens if I stop the patch suddenly after wearing it for several days?
A: Some people may develop withdrawal-like symptoms such as dizziness, nausea, vomiting, headache, or balance problems a day or more after removal, so contact your clinician if you feel unwell after stopping the patch.

Storage: Keep patches at room temperature in their sealed pouches, away from excess heat, moisture, and direct light, and store them out of reach of children and pets.

Handling: Only open the pouch right before use, apply the patch to clean, dry, hairless skin behind the ear, and wash your hands thoroughly with soap and water after applying or removing a patch to avoid getting medicine in your eyes.

Disposal: When you remove a patch, immediately fold it in half with the sticky sides pressed together and throw it in household trash in a secure place where children and animals cannot reach it; do not flush patches down the toilet or reuse them.